Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate Presented in part at the 39th annual meeting of the American Society of Clinical Oncology, Chicago, Illinois, May 30–June 3, 2003.
Show full item record

This item appears in the following Collection(s)

Search Deep Blue

Advanced Search

Browse by

My Account


Available Now

MLibrary logo